Related Experiment Video
Updated: Jul 15, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Hydrophobicity-Adaptive Polymers Trigger Fission of Tumor-Cell-Derived Microparticles for Enhanced Anticancer Drug
Haojie Liu1, Shiyi Xu1, Tuying Yong1,2,3,4,5
1National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
Abstract:
Tumor-cell-derived microparticles (MPs) can function as anticancer drug-delivery carriers. However, short blood circulation time, large-size-induced insufficient tumor accumulation and penetration into tumor parenchyma, as well as limited cellular internalization by tumor cells and cancer stem cells (CSCs), and difficult intracellular drug release restrict the anticancer activity of tumor-cell-derived MP-based drug-delivery systems. In this work, hydrophobicity-adaptive polymers based on poly(N-isopropylacrylamide) are anchored to tumor-cell-derived MPs for enhanced delivery of the anticancer drug doxorubicin (DOX). The polymers are hydrophilic in blood to prolong the circulation time of DOX-loaded MPs (DOX@MPs), while rapidly switching to hydrophobic at the tumor acidic microenvironment. The hydrophobicity of polymers drives the fission of tumor-cell-derived MPs to form small vesicles, facilitating tumor accumulation, deep tumor penetration, and efficient internalization of DOX@MPs into tumor cells and CSCs. Subsequently, the hydrophobicity of polymers in acidic lysosomes further promotes DOX release to nuclei for strong cytotoxicity against tumor cells and CSCs. The work provides a facile and simple strategy for improved anticancer drug delivery of tumor-cell-derived MPs.
Insights
Modified tumor-derived microparticles (MPs) effectively deliver anticancer drugs. Polymers enhance circulation, tumor penetration, and drug release, improving cancer treatment efficacy against tumor cells and cancer stem cells (CSCs).
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapeutics
Background:
- Tumor-cell-derived microparticles (MPs) show potential as drug carriers.
- Limitations include short circulation, poor tumor penetration, and inefficient cellular uptake.
- Challenges also exist in intracellular drug release for enhanced cytotoxicity.
Purpose of the Study:
- To enhance the anticancer drug delivery efficacy of tumor-cell-derived MPs.
- To overcome limitations of circulation time, tumor accumulation, and cellular internalization.
- To improve intracellular drug release and cytotoxicity against tumor cells and cancer stem cells (CSCs).
Main Methods:
- Anchoring hydrophobicity-adaptive polymers (poly(N-isopropylacrylamide)) to tumor-cell-derived MPs.
- Loading MPs with the anticancer drug doxorubicin (DOX).
- Evaluating the behavior of DOX-loaded MPs (DOX@MPs) in physiological and tumor microenvironments.
Main Results:
- Hydrophilic polymers prolonged circulation time of DOX@MPs in blood.
- Polymers became hydrophobic in the acidic tumor microenvironment, inducing MP fission into smaller vesicles.
- This facilitated enhanced tumor accumulation, deep penetration, and efficient internalization by tumor cells and CSCs.
- Hydrophobicity in acidic lysosomes promoted DOX release to nuclei, increasing cytotoxicity.
Conclusions:
- A facile strategy was developed for improved anticancer drug delivery using tumor-cell-derived MPs.
- Hydrophobicity-adaptive polymers enhance MP performance for cancer therapy.
- The approach shows promise for overcoming key challenges in MP-based drug delivery systems.
More Related Videos
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
05:08Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Cell Migration through Invadopodia
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules